These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12879425)

  • 1. D-dimer assay in Gaucher disease: correlation with severity of bone and lung involvement.
    Shitrit D; Rudensky B; Zimran A; Elstein D
    Am J Hematol; 2003 Aug; 73(4):236-9. PubMed ID: 12879425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-dimer assay in Egyptian patients with Gaucher disease: correlation with bone and lung involvement.
    Sherif EM; Tantawy AA; Adly AA; Kader HA; Ismail EA
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):176-84. PubMed ID: 21346558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
    Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
    Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased red blood cell aggregation in patients with Gaucher disease is non-inflammatory.
    Adar T; Ben-Ami R; Elstein D; Zimran P; Berliner S; Yedgar S; Barshtein G
    Clin Hemorheol Microcirc; 2008; 40(2):113-8. PubMed ID: 19029636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
    Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD
    Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism.
    Le Gal G; Righini M; Roy PM; Sanchez O; Aujesky D; Perrier A; Bounameaux H
    Arch Intern Med; 2006 Jan; 166(2):176-80. PubMed ID: 16432085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
    Piran S; Roberts A; Patterson MA; Amato D
    Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthopaedic manifestations of Gaucher disease.
    Lutsky KF; Tejwani NC
    Bull NYU Hosp Jt Dis; 2007; 65(1):37-42. PubMed ID: 17539760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase-activated receptor (PAR1) polymorphic variant correlates with thrombocytopenia in Gaucher disease.
    Altarescu G; Seror-Bukris O; Zimran A; Elstein D
    Blood Cells Mol Dis; 2010; 44(2):79-81. PubMed ID: 19969492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer as marker for microcirculatory failure: correlation with LOD and APACHE II scores.
    Angstwurm MW; Reininger AJ; Spannagl M
    Thromb Res; 2004; 113(6):353-9. PubMed ID: 15226089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease.
    Altarescu G; Zimran A; Michelakakis H; Elstein D
    Cytokine; 2005 Jul; 31(2):149-52. PubMed ID: 15919211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma.
    Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG
    Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.
    Zevin S; Abrahamov A; Hadas-Halpern I; Kannai R; Levy-Lahad E; Horowitz M; Zimran A
    Q J Med; 1993 Sep; 86(9):565-73. PubMed ID: 8255971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D-dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; De Maeseneer M; Hermsen JT; Trienekens PH; Hoogsteden H; Pattynama PM
    Semin Thromb Hemost; 2006 Oct; 32(7):678-93. PubMed ID: 17024595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operative technique and results of subtotal splenectomy for Gaucher disease.
    Guzzetta PC; Connors RH; Fink J; Barranger JA
    Surg Gynecol Obstet; 1987 Apr; 164(4):359-62. PubMed ID: 3563849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.
    Bloom BJ; Alario AJ; Miller LC
    J Rheumatol; 2009 Feb; 36(2):422-6. PubMed ID: 19040298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation of red blood cells in patients with Gaucher disease.
    Adar T; Ben-Ami R; Elstein D; Zimran A; Berliner S; Yedgar S; Barshtein G
    Br J Haematol; 2006 Aug; 134(4):432-7. PubMed ID: 16827817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.